AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Agilent Technologies at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Agilent Technologies brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 617. Its sessions cover RNA-based tumor profiling for molecular classification beyond fusion calling, and targeted long-read sequencing applied to hereditary cancer research. The company supplies instruments, consumables and software to diagnostic and life science laboratories.

OrganizationAMP 2026 Attendance
Agilent Technologies
Santa Clara, CA
Suppliers
Supplies instruments, consumables, software and services for life science, diagnostics and applied chemical laboratories.
Booth
Exhibiting at Booth 617
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
12:00pm–12:50pm
Beyond Fusion Detection: Scalable RNA-Based Tumor Profiling for Molecular Classification
RNA sequencing of tumours for fusion detection and expression-based classification, run through automated library prep.
Workshop
Fri, Nov 13
12:40pm–1:10pm
Resolving the Unresolvable: Targeted Long-Read Sequencing for Hereditary Cancer Research
Targeted long-read sequencing for hereditary cancer genes, covering capture panel design, sample prep and results in repetitive regions.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Agilent Technologies

Tell us what you sell and we’ll find the people at Agilent Technologies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction